HopeStage
Back to all studies
CompletedNCT00182000

D-cycloserine added to behavior therapy for obsessive-compulsive disorder

About this titleRead the official source — NCT00182000
Medication studyAges 18+OCD
The study in practice

Understand this study

Who was this study for?

This study was for people with OCD. Listed age limits: from 18 years. Other eligibility criteria applied.

Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNovember 2003
Recruitment status
Completed
Enrollment listed in the registry
33
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Not clearly listed
Age range
Over 18 Years
Official registry ID
NCT00182000
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled Medication Trial With D-Cycloserine for Individuals With OCD Currently Receiving Behavior Therapy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including seromycin.

Who was this study for?

This study was for people with OCD. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies